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Abstract
The day we understand the time evolution of subcellular elements at a level of detail com-
parable to physical systems governed by Newton’s laws of motion seems far away. Even so,
quantitative approaches to cellular dynamics add to our understanding of cell biology, provid-
ing data-guided frameworks that allow us to develop better predictions about, and methods
for, control over specific biological processes and system-wide cell behavior. In this paper,
we describe an approach to optimizing the use of transcription factors (TFs) in the context
of cellular reprogramming. We construct an approximate model for the natural evolution of
a cell cycle synchronized population of human fibroblasts, based on data obtained by sam-
pling the expression of 22,083 genes at several time points along the cell cycle. In order to
arrive at a model of moderate complexity, we cluster gene expression based on the division of
the genome into topologically associating domains (TADs) and then model the dynamics of
the TAD expression levels. Based on this dynamical model and known bioinformatics, such
as transcription factor binding sites (TFBS) and functions, we develop a methodology for
identifying the top transcription factor candidates for a specific cellular reprogramming task.
The approach used is based on a device commonly used in optimal control. Our data-guided
methodology identifies a number of transcription factors previously validated for reprogram-
ming and/or natural differentiation. Our findings highlight the immense potential of dynamical
models, mathematics, and data-guided methodologies for improving strategies for control over
biological processes.
Significance Statement
Reprogramming the human genome toward any desirable state is within reach; application of select
transcription factors drives cell types toward different lineages in many settings. We introduce the
concept of data-guided control in building a universal algorithm for directly reprogramming any hu-
man cell type into any other type. Our algorithm is based on time series genome transcription and
architecture data and known regulatory activities of transcription factors, with natural dimension
reduction using genome architectural features. Our algorithm predicts known reprogramming fac-
tors, top candidates for new settings, and ideal timing for application of transcription factors. This
framework can be used to develop strategies for tissue regeneration, cancer cell reprogramming,
and control of dynamical systems beyond cell biology.
Introduction
In 1989, pioneering work by Weintraub et al. successfully reprogrammed human fibroblast cells
to muscle cells via over-expression of transcription factor (TF) MYOD1, becoming the first to
demonstrate that the natural course of cell development could be altered [1]. In 2007, Yamanaka
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et al. changed the paradigm further by successfully reprogramming human fibroblast cells to an
embryonic-stem-cell-like state (induced pluripotent stem cells; iPSCs) using four TFs: POU5F1,
SOX2, KLF4, MYC. This showed that a differentiated cell state could be reverted to a more
pluripotent state [2].
These remarkable findings demonstrated that the genome is a system capable of being con-
trolled via an external input of TFs. In this context, determining how to push the cell from one
state to another is, at least conceptually, a classical problem of control theory [3]. The difficulty
arises in the fact that the dynamics – and even proper representations of the cell state and inputs
– are not well-defined in the context of cellular reprogramming. Nevertheless, it seems natural to
treat reprogramming as a problem in control theory, with the final state being the desired repro-
grammed cell. In this paper, we provide a control theoretic framework based on empirical data and
demonstrate the potential of this framework to provide novel insights into cellular reprogramming
[4, 5].
Our goal is to mathematically identify TFs that can directly reprogram human fibroblasts to a
desired target cell type. As part of our methodology, we create a model for the natural dynamics of
proliferating human fibroblasts. We couple data from bioinformatics with methods of mathematical
control theory–a framework which we dub data-guided control (DGC). Using time series data and
a natural dimension reduction through topologically associating domains (TADs), we capture the
natural dynamics of the cell, including the cell cycle.
We use this model to determine a principled way to identify the best TFs for efficient repro-
gramming of a given cell type toward a desired target cell type. Previously, selection of TFs for
reprogramming has been based largely on trial and error, typically relying on TF differential ex-
pression between cell types for initial predictions. Recently, Rackham et al. devised a predictive
method based on differential expression as well as gene and protein network data [6]. Our approach
is fundamentally different in that we take a dynamical systems point of view, opening avenues for
investigating efficiency (probability of conversion), timing (when to introduce TFs), and optimality
(minimizing the number of TFs and amount of input).
Using genomic transcription and architecture data, our method identifies TFs previously found
to reprogram human fibroblasts into embryonic stem cell-like cells and reprogram fibroblasts into
muscle cells. Our method also predicts TFs for conversion between human fibroblasts and many
additional target cell types. In addition, we show the efficacy of using TADs for genome dimension
reduction. Our analysis predicts the points in the cell cycle at which the insertion of TFs can most
efficiently affect a desired change of cell state. Implicit in this approach is the notion of distance
between cell types, which is measured in terms of the amount of transcriptional change required
to transform one cell type into another. In this way, we are able to provide a comprehensive
quantitative view of human cell types based on the respective distances between cell types.
Our framework separates into three parts:
1. Define the state. Use structure and function observations of the initial and target cell
types’ genomes to define a comprehensive state representation.
2. Model the dynamics. Apply model identification methods to approximate the natural
dynamics of the genome, from time series data.
3. Define and evaluate the inputs. Infer from bioinformatics (TF binding location and
function) where TFs can influence the genome, then quantify controllability properties with
respect to the target cell type.
The actual dynamics of the genome are undoubtedly very complicated, but as is often done in
mathematical modeling studies, we use measurements to identify a linear approximation. This will
take the form of a difference equation that is widely studied in the control systems literature, [7]
xk+1 = Akxk +Buk. (1)
In this case, the three items listed above correspond respectively to the value of the state xk at
time k, the time dependent state transition matrix Ak, and the input matrix B (along with the
input function uk).
2
Methods
Genome State Representation and Dimension Reduction: xk
The state representation x in Eq. 1 is the foundation for any control system and is critical for
controllability analysis. To fully represent the state of a cell, a high number of measurements
would need to be taken, including gene expression, protein level, chromatin conformation, and
epigenetic measurements. As an initial simplification, we assume that the gene expression profile
is a sufficient representation of the cell state.
Gene expression for a given cell is dependent on a number of factors, including (but not limited
to): cell type, cell cycle stage, circadian rhythm stage, and growth conditions. In order to best
capture the natural fibroblast dynamics from population-level data, time series RNA-seq was per-
formed on cells that were cell cycle and circadian rhythm synchronized in normal growth medium
conditions (See SI). Prior to data collection, all cells were temporarily held in the first stage of
the cell cycle, G0/G1, via serum starvation. Upon release into the cell cycle, the population was
observed every ∆t = 8 hours (h) for 56 h, yielding 8 time points (at 0, 8, 16, . . . , 56 h). Let gi,k
be the measured activity of gene i = 1, . . . , N at measurement time k = 1, . . . , 8, where N is the
total number of human genes observed (22,083). Analysis of cell-cycle marker genes indicated that
the synchronized fibroblasts took between 32-40 h to complete one cell cycle post growth medium
introduction, after which cells became largely unsynchronized (Fig. S1). Because of this, we define
K = 5 to be the total number of time points used for this model.
An obstacle to using g to represent x in a dynamical systems approach is the computational
feasibility of studying a system with over 20,000 variables, necessitating a dimension reduction.
Naïve dimension reductions such as partitioning the genome into 1 mega-base pair (Mb) bins
ignores inherent structural organization of the genome and obscures important intricacies of finer
resolutions. A comprehensive genome state representation should include aspects of both structure
and function, and simultaneously have low enough dimension to be computationally reasonable.
Along these lines, we propose a biologically inspired dimension reduction based on topologically
associated domains (TADs).
The advent of genome-wide chromosome conformation capture (Hi-C) allowed for the studying
of higher order chromatin structure and the subsequent discovery of TADs [8]. TADs are inherent
structural units of chromosomes: contiguous segments of the 1-D genome for which empirical
physical interactions can be observed [9]. Moreover, genes within a TAD tend to exhibit similar
activity, and TAD boundaries have been found to be largely cell-type invariant [9, 10, 11]. TADs
group structurally and functionally similar genes, serving as a natural dimension reduction that
preserves important genomic properties. Fig. 1 depicts an overview of this concept. We computed
TAD boundaries from Hi-C data via an algorithm that uses Fielder vector partitioning, described
in Chen et al. (See SI) [12].
Figure 1: Overview of TAD dimension reduction. (A) Partitioning the Hi-C matrix based on the
Fiedler vector. (B) Cartoon depiction of TAD genomic structure. (C ) TAD dimension reduction
summary.
Let tad(i) := j if gene i is contained within TAD j. We define each state variable xj,k to be the
expression level of TAD j = 1, . . . , N˜ at time k, where N˜ = 2, 245 is the total number of TADs that
contain genes. Specifically, xj,k is defined as the sum of the expression levels of all genes within
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the TAD, measured in reads per kilobase of transcript per million (RPKM), i.e.
xj,k :=
∑
i s.t.
tad(i)=j
gi,k. (2)
The vector of all TAD activities at measurement k is denoted with a single subscript xk ∈ RN˜×1, k =
1, . . . ,K.
State Transition Matrix: Ak
Given the data we have, perhaps the most direct way to model the evolution of TAD activity level
would be to assume a model of the form xk+1 = xk + y, where xk and xk+1 come from data, and
y is the vector difference of xk+1 and xk. However, the data could also be viewed in a different
way. Taken over a full cycle, the average value of the expression level of the 2,245 TADs is known,
within experimental error. Assuming that there is a function f which maps xk to xk+1, we can
subtract the steady state average, x¯, and focus on measuring the deviation from average as the
cycle evolves. With this in mind, we have f(x) = x¯ + A(x − x¯) where A is allowed to depend on
x’s location in the cell cycle. That is, we build a model for the variation of the cell cycle about
x¯. For the model to match data and capture variability over the cell cycle, we will need to have a
different A for each time step. Using the principle that A should differ as little from the identity
as possible, we let Ak be the identity plus a rank one matrix chosen to match the data, for each
time step k. In this case we have xk+1 − x¯ = Ak(xk − x¯).
We define a time dependent state transition matrix Ak.
Ak := IN˜ +
(xk+1 − xk)xᵀk
xᵀkxk
∈ RN˜×N˜ , k = 1, 2, 3, 4, 5 (3)
where IN˜ is the N˜ × N˜ identity matrix.
Input Matrix and Input Signal: B,uk
With the natural TAD-level dynamics established in the context of our control Eq. 1, we turn our
attention to quantifying methods for control.
A TF is a protein that can regulate a gene positively or negatively by binding to a specific
DNA sequence near a gene and encouraging or discouraging transcription. This is accomplished,
for example, by altering local chromatin conformation or by recruiting RNA polymerase II and
other transcriptional machinery [13]. The degree to which a TF activates or represses a gene
depends on the specific TF-gene interaction and most likely on a variety of nuclear subtleties and
intricacies that are difficult to quantify. Let wi,m be the theoretical regulation weight of TF m
on gene i, where wi,m > 0 (wi,m < 0) if TF m activates (represses) gene i, and m = 1, . . . ,M ,
where M is the total number of well-characterized TFs. Weights that are bigger in absolute value,
|wi,m|  0, indicate stronger transcriptional influence, and weights equal to zero, wi,m = 0, indicate
no influence.
Extensive TF perturbation experiments would be needed to determine wi,m for each TF m on
each gene i. Instead, we propose an alternative (simplified) method to approximate wi,m from exist-
ing, publicly available data for TF binding sites, gene accessibility, and average activator/repressor
activity. To determine the number of possible binding sites a TF m recognizes near gene i, we
scanned the reference genome for the locations of potential TF binding sites (TFBSs) (See SI).
Position frequency matrices (PFMs), which give information on TF-DNA binding probability, were
obtained for 547 TFs from a number of publicly available sources (∴ M = 547). Let ci,m be the
number of TF m TFBSs found within ±5kb of the transcriptional start site (TSS) of gene i (Fig.
S2). In our model, the magnitude of wi,m is proportional to ci,m. False negatives would include
distal TFBSs outside of the ±5kb window, while false positives would be erroneous TFBS matches.
Although many TFs can do both in the right circumstances, most TFs have tendency toward
either activator or repressor activity [13]. That is, if TFm is known to activate (repress) most genes,
we can say with some confidence that TF m is an activator (repressor), so wi,m ≥ 0 (wi,m ≤ 0) for
all i. To determine a TF’s function, we performed a literature search for all 547 TFs and labeled
299 as activators and 124 as repressors (See SI). The remaining TFs were labeled unknown for lack
of conclusive evidence for activator or repressor function. In the case of inconclusive evidence, the
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TF was evaluated as both an activator and a repressor in separate calculations. Here, we define
am as the activity of TF m, with 1 and -1 denoting activator and repressor, respectively, and the
sign of wi,m will be determined by am.
TFBSs are cell-type invariant since they are based strictly on the linear genome. However, it is
known that for a given cell type, certain areas of the genome may be opened or closed depending
on epigenetic aspects. To capture cell type specific regulatory information, we obtained gene
accessibility data through DNase-seq. DNase-seq extracts cell type specific chromatin accessibility
information genome-wide by testing the genome’s sensitivity to the endonuclease DNase I, and
sequencing the non-digested genome fragments. This data is used for our initial cell type to
determine which genes are available to be controlled by TFs [14]. Here, we define si be the DNase
I sensitivity information (accessibility; open/close) of gene i in the initial state, with 1 and 0
denoting accessible and inaccessible, respectively (See SI).
We approximate wi,m as
wi,m := amsici,m, (4)
so that the magnitude of influence is equal to the number of observed consensus motifs ci,m, except
when the gene is inaccessible (si = 0) in which case wi,m = 0.
Since we are working off a TAD-dimensional model, our input matrix B must match this
dimension. Let bm be a 2,245-dimensional vector, where the jth component is
bj,m :=
∑
i s.t.
tad(i)=j
wi,m (5)
and define a matrix B =
[
b1 b2 · · · bM
]
.
The amount of control input is captured in uk, which is a RM×1 vector representing the quantity
of the external TFs we are inputting to the system (cell) at time k. This can be controlled by
the researcher experimentally through manipulation of the TF concentration [15]. In this light, we
restrict our analysis to uk ≥ 0 for all k, as TFs cannot be subtracted from the cell. um,k is defined
as the amount of TF m to be added at time point k.
With all variables of our control Eq. 1 defined, we can now attempt to predict which TFs
will most efficiently achieve cellular reprogramming from some xI (initial state; fibroblast in our
setting) to xT (target state; any human cell type for which compatible RNA-seq data is available)
through manipulation of uk. An overview of our DGC framework is given in Fig. 2.
Figure 2: Data-guided control overview. (A) Summary of control equation variables. (B) Each
TAD is a node in a dynamic network. The blue connections represent the edges of the network
and are determined from time series fibroblast RNA-seq data. The miniature green plots represent
the expression of each TAD changing over time. The red arrows indicate additional regulation
imposed by exogenous transcription factors. (C ) A conceptual illustration of the problem: can we
determine transcription factors to push the cell state from one basin to another?
Selection of TFs
We consider different scenarios for the type of input regime. The first is assuming the input signal
is constant u1 = uk = u¯, intended to mimic empirical regimes where TFs are given at a single time
point. We will show that this method is theoretically inferior to inputting different TFs at different
points in the cell cycle in a later section.
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Eq. 1 has an explicit solution that is easily computed.
x2 = A1x1 +Bu1
x3 = A2A1x1 +A2Bu1 +Bu2
x4 = A3A2A1x1 +A3A2Bu1 +A3Bu2 +Bu3
...
Notice the expression for x4 depends the input matrix B and the input signal uk.
If xT is a target condition, then the Euclidean distance ‖ · ‖ can be used to measure how close
a state is to the target state, i.e.:
d = ‖xT − x6(uk)‖, (6)
where the notation x6(uk) is used to emphasize the dependence of x6 on uk. Considering all
possible input signals, one can compute the optimal control that finds the minimum distance for
a given initial and target cell type. Let u∗k denote the optimal uk used to minimize d, and d∗
denotes this minimum distance value.
We note here that when determining which TFs can be used to reach xT , it is often desirable and
more experimentally feasible to minimize the number of distinct TFs given to the cells. Transfection
of cells with multiple different TFs can lead to cell stress and death, and a lower efficiency of
transfection overall. Moreover, many experimentally confirmed direct reprogramming regimes use
≤4 TFs to achieve reprogramming. For these reasons, we set all indices of uk equal to zero, except
for indices corresponding to TFs that we choose.
We define pˆ to be a set of positive integers that refer to the indices of uk (read: TFs) that
are allowed to be non-zero (e.g. pˆ = {1, 4, 7} refers to TFs 1, 4, and 7). Let p be the number of
elements in pˆ. Given a set of TFs (pˆ), we determine the quantity and timing of TF input (u∗k) that
minimizes the difference (d∗) between the initial (xI) and target (xT ) cell state. Mathematically,
this can be written as
minimize
uk
‖xT − x6(uk)‖
subject to
{
um,k ≥ 0, if m ∈ pˆ
um,k = 0, if m 6∈ pˆ
(7)
We use MATLAB’s lsqnonneg function to solve Eq. 7, which gives u∗k and d∗.
Let d0 := ‖xT−xI‖, be the distance between initial and target states with no external influence.
We define the score µ := d0−d∗, which can be interpreted as the distance progressed towards target.
µ can be calculated for each pˆ and sorted (high to low) to determine which TF or TF combination
is the best candidate for direct reprogramming between xI and xT .
Remark: Subsets of TFs were chosen for each calculation based on the following criteria: ≥10-fold
expression increase in target state compared to initial state, and ≥4 RPKM in target state. These
criteria are used to select differentially expressed TFs and TFs that are sufficiently active in the
target state.
Results
Quantitative Measure Between Cell Types
In order to best utilize our algorithm to predict TFs for reprogramming, compatible data on target
cell types must be collected. For this, we explore a number of publicly available databases where
RNA-seq has been collected, along with RNA-seq data collected in our lab. The ENCODE Con-
sortium has provided data on myotubes and embryonic stem cells (ESCs) (See SI) [16]. The GTEx
portal provides RNA-seq data on a large variety of different human tissue types [17]. Although each
GTEx experiment is performed on tissue samples, thus containing multiple different cell types, we
use these data as more general cell state targets.
To give a numerical structure to cell type differences, conceptually similar to Waddington’s
epigenetic landscape, we calculate d0 between all cell types collected. Fig. 3A shows d0 values for
32 tissue samples collected from the GTEx portal, along with ESC, myotube, and our fibroblast
data (additional cell type d0 values shown in SI). Warmer colors (red) denote further distances
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between cell types. GTEx RNA-seq data is scaled to keep total RPKM difference between time
series fibroblast and GTEx fibroblast RNA-seq minimal (See SI).
Figure 3: Quantitative measure between cell types and transcription factor scores. (A) d0 values
between GTEx tissue types and ESC, myotube, and fibroblast. Tissue types and cell types with
black arrows have predicted transcription factors for reprogramming from fibroblasts shown in 3B.
(B) Table of predicted transcription factors for a subset of cell and tissue types. Top 5 transcrip-
tion factors for combinations of 1-3 shown. Green labeled transcription factors are either highly
associated with the differentiation process of the target cell type and/or validated for reprogram-
ming. These transcription factors are discussed in the main text. (C ) Time-dependent scores for
selected combinations of 3 transcription factors for fibroblast to ESC and fibroblast to “Heart -
Left ventricle". x-axis refers to time of transcription factor addition, y-axis refers to µ.
TF Scores
To assess our method’s predictive power, a subset of target cell types are presented here that have
either validated TF reprogramming methods or TFs highly associated with the target cell type.
Additional predicted TFs for reprogramming are included in SI. We note that though experimen-
tally validated TFs provide the best current standard for comparison, we believe experimental
validation with our predicted TFs may provide more efficient reprogramming results. For all re-
programming regimes presented in this section, fibroblast is used as the initial cell type due to the
availability of synchronized time series data, and all TFs are introduced at k = 1 [9].
For conversion of fibroblast to myotubes, the top predicted single input TFs are MYOG and
MYOD1, both of which are known to be crucial for myogenesis. While MYOD1 is the classic master
regulator reprogramming TF for myotube conversion, activation of downstream factor MYOG is
necessary for full conversion [18]. For fibroblast to ESC conversion, a number of TFs known
to be necessary for pluripotency are predicted, including MYCN, ZFP42, NANOG, and SOX2
[19]. With the knowledge that no single TF has been shown to fully reprogram a fibroblast to
an embryonic state, combinations of TFs are more informative for this analysis. The top scoring
combination of 3 TFs is MYCN, NANOG, and POU5F1–three well-known markers for pluripotency
[19]. Interestingly, POU5F1 scores poorly when input individually, but is within the top set of 3 TFs
when used in combination with MYCN and NANOG. Left ventricle reprogramming includes TFs
that are known to be necessary for natural differentiation in the top score for all 1-3 combinations.
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These include GATA4 (a known TF in fibroblast to cardiomyocyte reprogramming), HEY2, and
IRX4 [20, 21, 22].
Time-dependent TF Addition
Fibroblast to ESC conversion was of particular interest in our analysis as this is a well-studied
regime with a number of validated TFs (with a variety of reported efficiencies), and this conversion
is promising for its regenerative medicine application. High scoring TFs yield many that are known
markers for pluripotency, but the top combination of 3, MYCN, NANOG, and POU5F1, has not
been used specifically together, to our knowledge.
Since our method incorporates dynamical RNA-seq data, analysis can be extended to determine
the best time to input control for a given set of TFs. In our model, there are five possible input
times: 0, 8, . . . , 32 h. We assume a TF continues to influence the system at a constant value once
input until the final time (40 h). We restrict our analysis here to combinations of 3 TFs. This
gives 53 = 125 possible Time-dependent regimes to input the TFs; e.g. TF1, TF2, TF3 are input,
respectively, at times 0,0,0, or 0,0,8, or 0,0,16, or . . . or 32,32,24 or 32,32,32. Inputting a TF at
time k∗ can be viewed mathematically as requiring um,k = 0 for all k < k∗.
Time-dependent analysis of the top scoring ESC TFs reveals that scores vary widely depending
on the time of input. MYCN and NANOG show a strong preference for input at the beginning of
the cell cycle, while POU5F1 shows a slight preference for input towards the end of the cell cycle,
with the highest score achieved when MYCN and NANOG are input at 0 h and POU5F1 is input
at 32 h. Analysis on how the time of input control affects µ is shown in Fig. 3C. Time-dependent
analysis was also conducted for the top combination of 3 TFs for fibroblast to left ventricle. This
set includes GATA4, HEY2, and IRX4, all factors highly associated with the cardiac phenotype
[20, 21, 22]. This analysis predicted that the best reprogramming results would occur if GATA4 is
given immediately (0 h), with IRX4 and HEY2 given later (24 and 32 h, respectively).
Discussion
The results from this algorithm show promise in their prediction of known reprogramming TFs,
and demonstrate the importance of including time series data for gene network dynamics. Time of
input control has shown to have an impact on the end cell state, in line with what has been shown
in natural differentiation [23].
While we believe that this is the best model currently available for predicting TFs for repro-
gramming, we are aware of its limitations and assumptions. TAD-based dimension reduction is
based on the observation that genes within them correlate in expression over time, though we lack
definitive proof of regulation by shared transcriptional machinery [9]. This assumption was deemed
necessary for dimension reduction in the context of deriving transition matrix Ak. With finer time
steps in RNA-seq data, the assumption may not be necessary for TF prediction, at the cost of
increased computation time. Additionally, a 5kb window flanking the TSS of each gene was used
to ensure that all potential regulators are found, at the cost of potential inclusion of false positive
motifs.
GTEx data proved to be an invaluable resource for testing our algorithm, providing many target
states for TF prediction. It is important to note that these data are collected from cadaver tissue
samples; therefore the RNA-seq data is coming from a heterogeneous cell-type population and
may be enriched for stress factors known to be elevated after death (e.g. HSF4). Ideally, RNA-seq
data for target cells would be derived from a homogeneous population, with minimal experiment
collection variables. Future work includes the extension of this DGC approach to other target cell
types.
Although this program can score TFs relative to other TFs in a given reprogramming regime,
it is difficult to predict a µ threshold that would guarantee conversion. Additionally, rigorous
experimental testing will be required to validate these findings and determine how our u vector
translates to TF concentration. This is a product of the large number of assumptions that must
be made to develop the initial framework for a reprogramming algorithm. With finer resolution
in the time series gene expression, more subtle aspects of the genomic network may be observed,
allowing for better prediction.
Our proposed data-guided control framework successfully identified known TFs for fibroblast
to ESC and fibroblast to muscle cell reprogramming regimes. The framework rates individual TFs
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as well as sets of TFs. We employ a biologically-inspired dimension reduction via TADs, a natural
partitioning of the genome. This comprehensive state representation was the foundation of our
framework, and the success of our methods motivates further investigation of the importance of
TADs as functional units to control the genome.
A dynamical systems view of the genome allows for analysis of timing, efficiency, and optimality
in the context of reprogramming. Our framework is the first step toward this view. The successful
implementation of time-varying reprogramming regimes would open new avenues for direct repro-
gramming. Experimental verification of predicted regimes and development of methods to identify
optimal sets of TFs are planned for the near future. This template can be used to develop regimes
for changing any cell into any other cell, for applications that include reprogramming cancer cells
and controlling the immune system. Our DGC framework is well equipped for designing personal-
ized cellular reprogramming regimes. Finally, this framework can serve as a general technique for
investigating the controllability of networks strictly from data.
Methods and Materials
Hi-C and RNA-seq data were collected from cell cycle and circadian rhythm-synchronized pro-
liferating human fibroblasts of normal karyotype. Data were collected every 8 h, spanning 56 h.
Publicly available data was used for target cell types. Detailed materials and methods are provided
in Chen et al. and in SI [9].
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Supporting Information (SI)
Data
The fibroblast (FIB) data (Hi-C and RNA-seq) used for this application was originally collected
and published in a paper by Chen et al. [9]. We refer the reader to this paper for a full description
of technical protocols. Embryonic Stem Cell (ESC) and myotube (MT) data was downloaded
from NCBI-GEO (GSE23316 ENCODE Caltech RNA-seq and GSE52529) [16]. 53 different tissue
RNA-seq samples were downloaded from GTEx portal [17]. 51 different immune cell type RNA-seq
samples were obtained from the BLUEPRINT Epigenome project [24].
Hi-C and Construction of TADs
We computed TAD boundaries from genome-wide chromosome conformation capture (Hi-C) data
using an algorithm described in Chen et al. [12]. The algorithm was applied to averaged time
series Hi-C data from proliferating human fibroblast (FIB) at 100 kilo-base pair (kb) resolution,
which identified 2,562 TADs across all autosomal chromosomes (i.e. excluding Chromsomes X and
Y). Of the 2,562 TADs, 317 contained no genes and were excluded from our analysis, leaving 2,245
TADs. These TADs ranged in size from a few hundred kb to several Mb, and contained on average
9-10 genes (standard deviation of 18 genes); one gene at minimum, and 249 genes maximum.
Construction of B Matrix
TF binding site position frequency matrix (PFM) information was obtained from Neph et al. and
MotifDB, which is a collection of publicly available PFM databases such as, JASPAR, Jolma et
al. cispb_1.02, stamlab, hPDI, UniPROBE [25, 26]. TRANSFAC PFM information was included
as well. Motif scanning of the human reference genome (hg19) was performed using FIMO of the
MEME suite, in line with methods established by Neph et al. [25]. DNase-seq information for
human fibroblasts was derived from ENCODE for fibroblast (GSM1014531). If a narrow peak is
found within the ±5kb of a gene TSS, the region is classified as open. TF function information
was determined through an extensive literature search.
Scaling of RNA-seq
Due to differences in data collection procedures, the RNA-seq RPKM values obtained from the
GTEx portal were of lower value, on average, compared to our fibroblast dataset, thus favoring
repressor TFs for µ scoring. In order to account for this in our model, we scaled all GTEx RNA-seq
data by a factor that solves the equation
minimize
α
‖gFIB,UM − αgFIB,GTEX‖ (8)
where gFIB,UM is the gene-level RNA-seq vector average of our fibroblast data, gFIB,GTEX is the
gene-level RNA-seq vector of “Cells - Transformed fibroblasts” from the GTEx portal, and α is a
scalar that solves this equation. For this data, α = 2.6113 and all GTEx data used as a target
state was scaled by this factor.
Removal of MicroRNA
MicroRNA were removed from this analysis due to there high variance in RPKM values and
unpredictable function.
TF Scores - Additional GTEx Data
For fibroblast to Adipose-Subcutaneous, the highest scoring factor is EBF1, a known maintainer
of brown adipocyte identity, and a known promoter of adipogenesis in fibroblasts [27]. The 2nd
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highest scoring marker, PPARG, has been shown to be involved in adipose differentiation, and can
be used individually to achieve reprogramming from fibroblasts [28]. Curiously, ATF3 is implicated
here as being useful for adipocyte differentiation although its function has been shown to repress
PPARG and stymie cell proliferation [29]. Upon further research using time dependent addition,
ATF3 addition scores best when added towards the end of reprogramming process.
2 Brain tissue samples, Cerebellum and Hippocampus, both predict TFs necessary for natural
differentiation. Interestingly, our algorithm select different TFs for each conversion, with factors
linked specifically to each tissue. For Cerebellum, NEUROD1, has been shown to be required for
granule cell differentiation, while ZIC1 and ZIC4 are both known to promote cellebular-specific
neuronal function [30, 31]. The top scoring combination of 3 TFs are all similarly known to
be important in neurogenesis (NEUROD1, ZBTB18, UNCX) [32, 33]. Hippocampus TF scoring
includes FOXG1 as the top predicted factor, a factor specifically needed in hippocampus develop-
ment. OLIG2, FOXG1, and GPD1 are the top scoring set for hippocampus reprogramming, all of
which have been shown to been necessary for hippocampus function.
Colon TF scoring finds known differentiation factor in natural colon secretory linage develop-
ment, ATOH1, as the highest scoring individual factor [34]. The top scoring combination of 2
TFs includes ATOH1 along with CDX2, another known factor necessary for full differentiation of
colon cells, specifically small intestine maturation [35]. Liver cell reprogramming similarly finds
known factors for differentiation in the top score of all 3 combinations: HNF4A, CUX2, PROX1
[36, 37, 38]. All factor play a role in correct development of hepatic progenitor cell-types and
hepatic stem cells, the cell types just above in lineage differentiation.
TF Scores - BLUEPRINT Project Data
A number of immune cell types extracted from the BLUEPRINT Project revealed promising pre-
dicted TF results when fibroblast is used as the starting point [24]. d0 values between cell types
are shown in Fig. S4.
For fibroblast to macrophage direct reprogramming, a number of factors scoring highly in our
algorithm are known to play a role in macrophage reprogramming or the differentiation. SPI1
(along with CEBPA) has been verified experimentally to reprogram fibroblasts into macrophage-
like cells [39]. IKZF1 has been shown to be crucial for macrophage polarization via the IRF4/IRF5
pathway [40]. MYB has been shown to be crucial for the upstream cell type HSC [41].
For fibroblast to HSC direct reprogramming, the top scoring individual factor is highly associ-
ated with the target phenotype and has been shown to support HSC growth and regeneration [42].
ERG (in combination with GATA2, LMO2, RUNX1c, and SCL) is a confirmed reprogramming
factor for fibroblast to HSC in mice [43].
For fibroblast to erythroblast reprogramming, ERG is a promising factor as it is required for
the maintenance of the upstream cell type HSC [43]. NFIA is shown to promote the erythroid
lineage from HSC differentiation [44].
Alternative Computation of u
Below is an example of how u can be computed without the constraint that uk,m ≥ 0. Assume
uk := u¯ is constant for all t. Then
xk+1 = Akxk +Buk. (9)
can be written as
x4 = A3A2A1x1 + Cu¯, (10)
where
C := A3A2B +A3B +B
We seek the control u¯ that minimizes the distance between x(3) and the target xT :
min
u¯
‖xT −A3A2A1x1 − Cu¯‖. (11)
We can see that an exact solution exists if
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xT −A3A2A1x1 ∈ span(C), (12)
and is given by
A3A2A1x1 + Cu¯ = xT (13)
Cu¯ = xT −A3A2A1x1 (14)
u¯ = C† (xT −A3A2A1x1) , (15)
where C† denotes the Moore-Penrose pseudoinverse of the matrix C, computed using the singular
value decomposition of C. Even when Eqn (12) is not satisfied, it is well established that the
control (15) solves (11) .
Define
d =
∥∥∥∥(IN − CC†)(xT −A3A2A1x1)∥∥∥∥ (16)
µ := d0 − d∗ (17)
µ can be used to compare between potential TFs for a defined initial state (xI), target state (xT ),
and TF number (p). The larger the value of µ, the higher the relative score for its corresponding
TF set.
We note that accurate TF predictions for some desired target cell type may not depend on
minimizing distance alone, but also the amount of “energy" required for the system to reach d∗.
We denote energy here with µ2 and define it as:
e(u) =
K−1∑
k=0
uTk · uk = µ2. (18)
µ2 is analogous to the amount of a TF that needs to be added to the system to achieve d∗.
In the case where two different TFs achieve the same µ score, µ2 can be computed to decide the
better candidate (i.e. lower µ2 is better TF).
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SI Figures
Figure S1: Analysis of cell cycle marker gene expression. Gene expression RNA-seq data for 39
genes that have been shown in the literature to be cell cycle regulated [45]. Cell cycle phases
shown include (A) G1/S, (B) S, (C ) G2, (D) G2/M. Raw data of gene expression over time (left),
with smoothed/interpolated expression over time with standard deviation (right). The expression
curves for each gene have been standardized by subtracting their mean and dividing by the standard
deviation over the eight time points. x-axis denotes sample time point k, referring to 0, 8, 16, . . . ,
56 h after growth medium introduction. y-axis is normalized expression.
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Figure S2: Visualization of input matrix B. (A) Visualization of the 22,083×547 ci,m matrix:
identified TF-to-gene interactions based on TFBSs. The color at entry (i,m) represents how many
transcription factor m TFBSs were observed within ±5kb of gene i’s TSS. The color axis has
been truncated to [0, 10] but note that more than 10 TFBSs were observed for many (gene,TF)
pairs. Certain columns (TFs) are dramatically highlighted compared to others, some of which have
been labeled by name along the horizontal axis. Some gene names are labeled along the vertical
axis, none of which particularly stand out. Both genes and TFs are sorted alphabetically. (B) A
histogram for the non-zero values of ci,m. The log-scale on the vertical axis emphasizes that most
of the gene TSS regions contain much less than 25 TFBSs for a given TF. The SP1 TFBS, for
example, is observed 249 times in a 10kb TSS centered on a gene.
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Figure S3: Quantitative measure between cell types and transcription factor scores. (A) d0 values
between all GTEx tissue types. (B) TF scores for an extended list of target cell types. xI =
fibroblast
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Figure S4: Quantitative measure between cell types and TF scores for BLUEPRINT Project
database. (A) d0 values between BLUEPRINT Project cell types. (B) TF scores for an extended
list of target cell types. xI = fibroblast
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